Home › Funds › J. Safra Sarasin Holding AG › JNJ

J. Safra Sarasin Holding AG position in JNJ

JOHNSON JOHNSON · Health Care

J. Safra Sarasin Holding AG reported holding 414,478 shares of JNJ (JOHNSON JOHNSON) in its Q3 2026 13F filing — a position valued at US$103.5M, representing 1.47% of its reported portfolio and ranking #11 among its reported holdings. J. Safra Sarasin Holding AG has disclosed JNJ holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)414.48K sh
Reported value held$103.45M
Portfolio Weight1.47%
First reportedQ2 2024
Last changeReduce
Updated2026-10-26

Last updated: 2026-10-26 · Source: SEC EDGAR Form 13F-HR

How J. Safra Sarasin Holding AG's JNJ position evolved

J. Safra Sarasin Holding AG first disclosed a stake in JNJ in Q2 2024 at 324,204 shares (US$47.4M). The position peaked in Q1 2026 at 481,585 shares, worth US$117.7M. Across 10 filings, J. Safra Sarasin Holding AG increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 414,478 shares valued at US$103.5M — a reduction of -42,490 shares quarter over quarter.. Notable position changes include a 27% increase in Q2 2025 (shares rose 22% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 324.20K $47.37M New
Q3 2024 312.11K $50.58M Reduce
Q4 2024 321.65K $46.52M Add
Q1 2025 369.98K $61.36M Add
Q2 2025 470.52K $71.87M Add
Q3 2025 486.68K $90.24M Add
Q4 2025 478.80K $99.09M Reduce
Q1 2026 481.58K $117.67M Add
Q2 2026 456.97K $113.10M Reduce
Q3 2026 414.48K $103.45M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has J. Safra Sarasin Holding AG held JNJ?

J. Safra Sarasin Holding AG has disclosed JNJ holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is J. Safra Sarasin Holding AG's current position in JNJ?

As of Q3 2026, J. Safra Sarasin Holding AG holds 414.48K shares of JNJ (JOHNSON JOHNSON), valued at $103.45M, representing 1.47% of its reported portfolio and ranking #11.

Has J. Safra Sarasin Holding AG been buying or selling JNJ?

In the latest 13F filing (Q3 2026), J. Safra Sarasin Holding AG reduced its position in JNJ. The position peaked in Q1 2026 at 481.58K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.